| A hemophilia A mouse model for the in vivo assessment of emicizumab function S Ferrière, I Peyron, OD Christophe, C Kawecki, C Casari, V Muczynski, ... Blood, The Journal of the American Society of Hematology 136 (6), 740-748, 2020 | 54 | 2020 |
| The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells B Gangadharan, M Ing, S Delignat, I Peyron, M Teyssandier, SV Kaveri, ... Haematologica 102 (2), 271, 2017 | 44 | 2017 |
| Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter Y Repessé, I Peyron, JD Dimitrov, S Dasgupta, EF Moshai, C Costa, ... haematologica 98 (10), 1650, 2013 | 44 | 2013 |
| To serve and protect: the modulatory role of von Willebrand factor on factor VIII immunogenicity RB Hartholt, AS van Velzen, I Peyron, A Ten Brinke, K Fijnvandraat, ... Blood reviews 31 (5), 339-347, 2017 | 42 | 2017 |
| Antibody-mediated catalysis: induction and therapeutic relevance A Mahendra, M Sharma, DN Rao, I Peyron, C Planchais, JD Dimitrov, ... Autoimmunity reviews 12 (6), 648-652, 2013 | 32 | 2013 |
| Heme binds to factor VIII and inhibits its interaction with activated factor IX Y Repessé, JD Dimitrov, I Peyron, EF Moshai, L Kiger, S Dasgupta, ... Journal of Thrombosis and Haemostasis 10 (6), 1062-1071, 2012 | 30 | 2012 |
| Storage-induced platelet apoptosis is a potential risk factor for alloimmunization upon platelet transfusion A Saris, I Peyron, PF Van der Meer, TB Stuge, JJ Zwaginga, SM Van Ham, ... Frontiers in immunology 9, 1251, 2018 | 26 | 2018 |
| Hunting down factor VIII in the immunopeptidome RB Hartholt, I Peyron, J Voorberg Cellular Immunology 301, 59-64, 2016 | 24 | 2016 |
| Complement C3 is a novel modulator of the anti-factor VIII immune response J Rayes, M Ing, S Delignat, I Peyron, L Gilardin, CW Vogel, DC Fritzinger, ... haematologica 103 (2), 351, 2018 | 22 | 2018 |
| Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells I Peyron, RB Hartholt, L Pedró-Cos, F van Alphen, A Ten Brinke, N Lardy, ... Haematologica 103 (1), 172, 2018 | 21 | 2018 |
| Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ J Hrdinová, FC Verbij, PHP Kaijen, RB Hartholt, F van Alphen, N Lardy, ... Haematologica 103 (6), 1083, 2018 | 18 | 2018 |
| Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells RB Hartholt, A Wroblewska, E Herczenik, I Peyron, A Ten Brinke, ... Journal of Thrombosis and Haemostasis 15 (2), 329-340, 2017 | 18 | 2017 |
| Relevance of the materno-fetal interface for the induction of antigen-specific immune tolerance A Mimoun, S Delignat, I Peyron, V Daventure, M Lecerf, JD Dimitrov, ... Frontiers in immunology 11, 810, 2020 | 17 | 2020 |
| The ADAMTS131239–1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope L Gilardin, S Delignat, I Peyron, M Ing, YC Lone, B Gangadharan, ... Haematologica 102 (11), 1833, 2017 | 16 | 2017 |
| Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications I Peyron, C Kizlik‐Masson, MD Dubois, S Atsou, S Ferrière, CV Denis, ... Research and Practice in Thrombosis and Haemostasis 4 (7), 1087-1100, 2020 | 15 | 2020 |
| Haemarthrosis and arthropathy do not favour the development of factor VIII inhibitors in severe haemophilia A mice. I Peyron, JD Dimitrov, S Delignat, B Gangadharan, C Planchais, ... Haemophilia 21 (1), 2015 | 15 | 2015 |
| Non-inhibitory antibodies inducing increased emicizumab clearance in a severe hemophilia A inhibitor patient A Harroche, T Sefiane, M Desvages, D Borgel, D Lasne, C Casari, ... Haematologica 106 (8), 2287, 2021 | 14 | 2021 |
| The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages FC Verbij, N Sorvillo, PHP Kaijen, J Hrdinova, I Peyron, R Fijnheer, ... Blood advances 1 (5), 293-305, 2017 | 11 | 2017 |
| Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A I Peyron, JD Dimitrov, S Delignat, B Gangadharan, A Srivastava, ... Cellular Immunology 325, 64-68, 2018 | 7 | 2018 |
| KB-V13A12, a novel nanobody-based therapeutic molecule for the treatment of von Willebrand disease I Peyron, C Casari, OD Christophe, PJ Lenting, CV Denis Int Soc Thromb Haemost, 2023 | 5 | 2023 |
Jordan D DimitrovINSERM在 inserm.fr 的电子邮件经过验证
